There were 251 press releases posted in the last 24 hours and 441,886 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
GeneTx and Ultragenyx Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image